Eye Care Updates



By: | Tags: , , , | Comments: 0 | February 16th, 2016

Because “age-related macular degeneration” (AMD) is the leading cause of vision loss and blindness in Americans aged 65 years and older, any information about a potential new treatment is welcomed. As a starting point in searching for new ways to treat AMD, researchers noted that people with highly pigmented and darker-colored eyes are less prone to developing AMD and more likely to have higher levels of a chemical called L-DOPA, which is prescribed to Parkinson’s patients (who have low levels of this dopamine precursor in their brains). When researchers examined the records of people prescribed L-DOPA, they found that they were less likely to develop AMD, and when they did, it began much later. Clinical trials will follow.

At MAYO EYE CENTER, our goal is to provide the most accurate medical diagnoses, new treatment options, and complete eye care to every patient. Please call 662-234-3937 to schedule an appointment. We’re located at 2890 South Lamar Blvd., where we provide proficient eye care for AMD and other eye diseases and conditions. We’re “Setting the standard for patient-centered eye care in North Central Mississippi.”

You must be logged in to post a comment.